StockTipsArenaBeta

BUY Thyrocare Technologies Limited — ICICI Securities

BUYThyrocare Technologies Limited
Thyrocare Technologies share price target & all analyst calls

byICICI SecuritiesHorizon: NA (inferred 1 year)24 Jul 2026via Moneycontrol Broker Research

Entry₹564.25Inferred
Target₹650
Total upside +15.20% (call closed)
Stop lossNot given
Exit₹65011 Aug 2026, 12:08 pm
Target hit+15.20%0.00%upside left
Follow ICICI Securities for new calls(67% target hit, 1025 closed calls)Get alertsWatch THYROCARE for new buy/sell callsGet alertsSee 2 active Long-term calls on THYROCARESee 161 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 11 Aug 2026
3 supporting4 neutral0 opposing
Supports the BUY call (3)

Thyrocare Technologies reported robust Q1FY27 results with revenue up 24% YoY to INR 240.02 Cr and PAT up 34% YoY to INR 51.33 Cr. The company also expanded into Specialty Diagnostics.

BSE · Company Update·23 Jul · 3w ago

(opens in new tab)

1 other SEBI-registered advisor has an active long-term BUY call on this stock

Advisor consensus · same horizon·23 Jul · 3w ago

Neutral / worth noting (4)

Thyrocare Technologies Ltd announced the outcome of its Board Meeting held on July 23, 2026. The board approved the unaudited financial results for the quarter ended June 30, 2026, along with the limi

BSE · Board Meeting·23 Jul · 3w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Thyrocare Technologies

All analyst calls on Thyrocare Technologies

More from ICICI Securities

Every call and its outcome